Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Bares

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 24, 2007
Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based, intensity-modulated radiation therapy techniqueUte Ganswindt, Frank Paulsen, Stefan Corvin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 3, 2004
PET with [18F]fluorothymidine for imaging of primary breast cancer: a pilot studyBrigitte Smyczek-Gargya, Nikos Fersis, Helmut Dittmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 5, 2003
[18F]FLT PET for diagnosis and staging of thoracic tumoursHelmut Dittmann, Bernhard Matthias Dohmen, Frank Paulsen, et al.
Nuclear Medicine Communications|August 21, 2004
The benefit of functional-anatomical imaging with [18F]fluorodeoxyglucose utilizing a dual-head coincidence gamma camera with an integrated X-ray transmission system in non-small cell lung cancerSusanne M Eschmann, Michael Bitzer, Frank Paulsen, et al.
World Journal of Urology|January 22, 2004
The role of [(18)F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors--prospects for managementAnna C Pfannenberg, Karin Oechsle, Carsten Bokemeyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 10, 2006
Low dose non-enhanced CT versus standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning in non-small cell lung cancerAnna C Pfannenberg, Philip Aschoff, Klaus Brechtel, et al.
Nuclear Medicine and Biology|February 17, 2009
3'-Deoxy-3'-[(18)F]fluorothymidine (FLT) uptake in breast cancer cells as a measure of proliferation after doxorubicin and docetaxel treatmentHelmut Dittmann, Ajnur Jusufoska, Bernhard Matthias Dohmen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2006
Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multiphase CT imagingKlaus Brechtel, Magnus Klein, Monika Vogel, et al.
The Journal of Urology|January 22, 2008
The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminomaStefan Hinz, Mark Schrader, Carsten Kempkensteffen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2010
PET/CT with 18F-FLT: does it improve the therapeutic management of metastatic germ cell tumors?Christina Pfannenberg, Philip Aschoff, Helmut Dittmann, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
International Journal of Radiation Oncology, Biology, Physics|January 24, 2007
Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based, intensity-modulated radiation therapy techniqueUte Ganswindt, Frank Paulsen, Stefan Corvin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 3, 2004
PET with [18F]fluorothymidine for imaging of primary breast cancer: a pilot studyBrigitte Smyczek-Gargya, Nikos Fersis, Helmut Dittmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 5, 2003
[18F]FLT PET for diagnosis and staging of thoracic tumoursHelmut Dittmann, Bernhard Matthias Dohmen, Frank Paulsen, et al.
Nuclear Medicine Communications|August 21, 2004
The benefit of functional-anatomical imaging with [18F]fluorodeoxyglucose utilizing a dual-head coincidence gamma camera with an integrated X-ray transmission system in non-small cell lung cancerSusanne M Eschmann, Michael Bitzer, Frank Paulsen, et al.
World Journal of Urology|January 22, 2004
The role of [(18)F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors--prospects for managementAnna C Pfannenberg, Karin Oechsle, Carsten Bokemeyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 10, 2006
Low dose non-enhanced CT versus standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning in non-small cell lung cancerAnna C Pfannenberg, Philip Aschoff, Klaus Brechtel, et al.
Nuclear Medicine and Biology|February 17, 2009
3'-Deoxy-3'-[(18)F]fluorothymidine (FLT) uptake in breast cancer cells as a measure of proliferation after doxorubicin and docetaxel treatmentHelmut Dittmann, Ajnur Jusufoska, Bernhard Matthias Dohmen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2006
Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multiphase CT imagingKlaus Brechtel, Magnus Klein, Monika Vogel, et al.
The Journal of Urology|January 22, 2008
The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminomaStefan Hinz, Mark Schrader, Carsten Kempkensteffen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2010
PET/CT with 18F-FLT: does it improve the therapeutic management of metastatic germ cell tumors?Christina Pfannenberg, Philip Aschoff, Helmut Dittmann, et al.
Pageof 6